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Exosomes, which are expected to be delivery systems for biomolecules such as nucleic acids, 
are collected by several methods. However, the effect of exosome isolation methods on the 
characteristics of exosomes as drug carriers, such as recovery efficiency after sterile filtration 
and pharmacokinetics, has not been investigated despite the importance of these 
characteristics for the development of exosome-based delivery systems. In the present study, 
exosomes collected from murine melanoma B16-BL6 cells by several methods were 
compared with respect to dispersibility, recovery rate after filtering, and clearance from the 
blood circulation in mice. The exosomes were collected by three ultracentrifugation-based 
methods: simple ultracentrifugation/pelleting (pelleting method), ultracentrifugation with an 
iodixanol cushion (cushion method), and ultracentrifugation on an iodixanol density gradient 
(gradient method). The isolation methods had little effect on the particle number of exosomes. 
In contrast, transmission electron microscopy observation and size distribution measurement 
using tunable resistive pulse sensing indicated that the exosomes of the gradient method were 
more dispersed than the others. The exosomes were labeled with Gaussia luciferase and 
intravenously injected into mice. Clearance of injected exosomes from the blood circulation 
did not significantly change with isolation methods. When the exosomes were filtered using a 
0.2-μm filter, the recovery rate was 82% for the exosomes of the gradient method, whereas it 
was less than 50% for the others. These results indicate that the exosome isolation method 
markedly affects the dispersibility and filtration efficiency of the exosomes. 
 







Exosomes are extracellular vesicles with a diameter of 30–150 nm that contain biomolecules 
including RNAs and proteins [1-3]. Exosomes are secreted from most types of cells and play 
roles in intercellular communication. Exosomes derived from specific cells have therapeutic 
potential. For example, exosomes derived from mesenchymal stem cells exert protective 
effects on myocardial ischemia/reperfusion injury [4]. Thus, exosomes themselves are 
expected to be used in disease treatments. They are also expected to be used as a 
biocompatible and efficient delivery carrier given that they are endogenous intercellular 
delivery carriers that transfer biomolecules including RNAs and proteins [5-7]. Exosomes as 
well as exosome-mimetic vesicles may be used to deliver therapeutic molecules such as small 
interfering RNAs, microRNAs (miRNAs), and small-molecule drugs including curcumin, 
doxorubicin, and porphyrin to target cells [8-12].  
Exosomes are usually collected from cell culture medium in such applications as 
delivery carrier and therapeutic treatment. There are several methods for isolating exosomes 
from the medium such as ultracentrifugation-based, solvent precipitation, column 
chromatography, and immunoaffinity methods [13]. The most commonly used method of 
isolation is the ultracentrifugation-based method. This method has a low cost, a low risk of 
contamination with separation reagent, and allows collection of large numbers of exosomes 
[4, 11]. Several ultracentrifugation-based methods have been developed for isolating 
exosomes. Another frequently used method is based on solvent precipitation [14]. This 
method is performed by incubation of samples with solvent reagent followed by 
centrifugation at a relatively low speed, and it does not require ultracentrifugation. The 
isolation methods influence the composition of miRNA and protein of exosomes [15, 16] as 
well as exosome morphology [17]. However, little is known about the effect of isolation 
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methods on the yield and physicochemical properties of exosomes, such as size, zeta 
potential, and dispersibility, despite the fact that these parameters affect the characteristics of 
exosomes as a delivery carrier and may change the therapeutic effect and delivery efficiency 
of exosome-based treatments. Although a few studies have compared the yield and 
physicochemical properties of exosomes obtained by different methods [18, 19], whether or 
not differences in physicochemical properties influence the characteristics of exosomes as 
drug carriers has not been investigated. 
In the present study, we selected the solvent precipitation method and three 
ultracentrifugation-based methods, namely, simple ultracentrifugation/pelleting (pelleting 
method), ultracentrifugation with a cushion at the bottom of the tubes (cushion method), and 
density gradient ultracentrifugation (gradient method) as exosome isolation methods and 
investigated the effects of these isolation methods on the characteristics of the collected 
exosomes. We used B16-BL6 murine melanoma cells to obtain exosomes because these cells 
produce large numbers of exosomes and B16 cell line-derived exosomes have frequently 
been characterized [2, 20]. The fusion protein of Gaussia luciferase (gLuc) and lactadherin 
(gLuc-LA) was then used as a probe to evaluate the effects of the methods on the clearance of 
exosomes from the blood circulation [21, 22]. 
 
Materials and Methods 
Cell culture and transfection 
B16-BL6 murine melanoma cells were obtained and cultured as described previously [21]. 
Plasmid DNA encoding gLuc-LA was constructed in the previous study [21]. To obtain 
gLuc-LA-labeled exosomes, plasmid DNA encoding gLuc-LA was transfected to B16-BL6 
cells with polyethyleneimine (PEI) “max” (Polysciences, Warrington, PA, USA). Briefly, 
128 μL PEI “max” solutions of 0.323 mg/mL, pH 8.0, and 16 μg plasmid DNA were 
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individually diluted to 500 μL with 150 mM NaCl. They were mixed and incubated at 15 min 
to make a complex. The solution was added to the cells. The medium was changed to 
Opti-MEM 4 h after transfection, and cells were incubated for additional 24 h. 
 
Exosome collection 
Cells were seeded in 150-mm dishes at a cell number of 5.0 × 106 cells per dish and cultured 
for 24 h. Then, the cell culture medium was removed and cells were washed thrice with 
phosphate-buffered saline (PBS). Next, 30 mL of Opti-MEM was added to the dish and the 
cells were incubated for additional 24 h. The culture medium was processed before 
ultracentrifugation by differential centrifugation at 300×g for 10 min, 2,000×g for 20 min, 
and 10,000×g for 30 min to remove cell debris and large vesicles. In addition, the medium 
was filtered with a 0.2-μm syringe filter. All the ultracentrifugation steps described below 
were performed using a Himac CP80WX ultracentrifuge (Hitachi Koki, Tokyo, Japan). 
In the pelleting method, the processed cell culture medium was spun at 100,000×g in 
an angle rotor (P50AT2, Hitachi Koki) for 1 h to obtain pellets containing exosomes. The 
pellet was then resuspended in PBS and spun again at 100,000×g in the angle rotor for 1 h. 
The exosomes obtained were resuspended in PBS. 
In the cushion method, 9 mL of the processed cell culture medium was overlaid onto 
40% OptiPrep (Axis-Shield PoC, Oslo, Norway) in 0.25 M sucrose/10 mM Tris-HCl, pH 7.5 
and was spun at 100,000×g in a swinging-bucket rotor (P40ST, Hitachi Koki) for 1 h. An 
aliquot from the border zone of the medium and the OptiPrep was collected and resuspended 
in PBS and was spun at 100,000×g in the angle rotor for 1 h to obtain pellets containing 
exosomes. The exosomes were resuspended in PBS. 
In the gradient method, 40%, 20%, 10%, and 5% OptiPrep solutions were prepared by 
dilution of a stock solution of OptiPrep with 0.25 M sucrose/10 mM Tris-HCl, pH 7.5. The 
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gradient was formed by sequentially layering 2.5 mL of each solution in descending order of 
density. The processed cell culture medium was concentrated to 1 mL using ultrafiltration 
(100k), layered on the top of the gradient layer, and spun at 100,000×g in the swinging 
bucket rotor for 18 h. Then, 1 mL of each fraction was collected sequentially from the top 
and numbered by collection order. Thus, the density of the collected fraction increased with 
fraction number. It was expected that exosomes would be recovered in fraction 9, based on 
the density of this fraction. After confirmation by a preliminary experiment that exosome 
marker proteins were detected mostly in this fraction, the fraction was used without 
additional treatment. In preliminary experiments, we confirmed that iodixanol remaining in 
the sample did not influence the assays, including filtration and pharmacokinetic analysis 
(unpublished results). 
In solvent precipitation, exosomes were collected from the processed cell culture 
medium using Exoquick-TC (System Biosciences, Mountain View, CA, USA) according to 
the manufacturer’s instruction. 
 
Western blotting 
Exosome samples (0.05 μg protein) and cell lysate of B16BL6 (1 μg protein) were reduced 
by addition of 100 mM dithiothreitol and heat treatment at 95°C for 3 min. The samples were 
then electrophoresed on 10% sodium dodecyl sulfate-polyacrylamide gel. Proteins were 
transferred from the gel to polyvinylidene fluoride membrane. The membrane was soaked 
with Blocking One (Nacalai Tesque, Kyoto, Japan) for 30 min. Then the membrane was 
soaked with antibody solutions to detect Alix and heat shock protein (HSP) 70, both of which 
are exosome marker proteins. To detect Alix, monoclonal mouse anti-Alix antibody (BD 
Biosciences, San Jose, CA, USA) was used at 1:1000 dilution, followed by anti-mouse IgG1 
horseradish peroxidase-conjugated antibody (Life Technologies, Grand Island, NY, USA) at 
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1:1000 dilution. To detect HSP70, monoclonal mouse anti-HSP70 antibody (Cell Signaling 
Technology, Danvers, MA, USA) was used at 1:2000 dilution, followed by goat anti-rabbit 
IgG antibody conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA) at 1:5000 dilution. To detect CD63, polyclonal rabbit anti-CD63 antibody (Santa 
Cruz Biotechnology) was used at 1:200 dilution, followed by goat anti-rabbit IgG antibody 
conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 
1:5000 dilution. To detect calnexin, polyclonal rabbit anti-calnexin antibody (Santa Cruz 
Biotechnology) was used at 1:200 dilution, followed by goat anti-rabbit IgG antibody 
conjugated with horseradish peroxidase (Santa Cruz Biotechnology) at 1:5000 dilution. The 
membrane was soaked with Immobilon Western Chemiluminescent HRP Substrate (Merck 
Millipore, Billerica, MA, USA), and chemiluminescence was observed with a LAS3000 
instrument (Fujifilm, Tokyo, Japan). 
 
Transmission electron microscopy (TEM) 
Exosomes were fixed in 4% paraformaldehyde and layered on a carbon/Formvar film-coated 
TEM grid (Okenshoji Co., Ltd., Tokyo, Japan) for 20 min. The grids were treated with 1% 
glutaraldehyde and washed eight times with dH2O for 2 min. They were then stained with 1% 
uranyl acetate for 10 min. Observation was performed with a transmission electron 
microscope (Hitachi H-7650, Hitachi High-Technologies Corporation, Tokyo, Japan). To 
measure Feret’s diameter of the particles, TEM images were analyzed using ImageJ software 






Estimation of exosome amounts was performed with the Quick Start Bradford protein assay 
(BioRad, Hercules, CA, USA) according to the manufacturer’s instructions.  
 
Tunable resistive pulse sensing (TRPS) 
Particle number and particle size of exosomes were measured with a qNano instrument (Izon 
Science Ltd, Christchurch, New Zealand) with the NP100 nanopore according to the 
manufacturer’s instructions. For the measurements, PBS was used as a buffer. Voltage was 
set to achieve approximately 100 nA current. Using a variable pressure module, 0.7 kPa of 
pressure was applied. Collected data were processed by Izon Control Suite software version 
3.2. Calibration was performed using data obtained by measuring control reagent (CPC100B; 
Izon Science) diluted 1:1000 with buffer. 
 
Measurement of zeta potential 
Zeta potential of the collected exosomes was determined at 25 °C with a Zetasizer Nano ZS 
(Malvern Instruments, Malvern, UK) and DTS 1070 disposable capillary cell. For 
measurement, exosomes were diluted with distilled water (1:100). 
 
Confirmation of labeling of exosomes with gLuc-LA 
Labeled exosome samples (1 × 109 RLU/s) were electrophoresed on 10% sodium dodecyl 
sulfate-polyacrylamide gel. The gel was washed with 2.5 % Triton X-100 for 30 min twice 
and PBS for 30 min. Then the gel was soaked with a substrate in a sea pansy luciferase assay 
system (Picagene Dual; Toyo Ink, Tokyo, Japan). Chemiluminescence was observed with a 
LAS3000 instrument. To confirm linear relationship between the amount of exosomes and 
the signal intensity of gLuc, labeled exosomes were serially diluted and gLuc activity was 
measured. Labeling of exosomes by gLuc-LA had little effect on size and zeta potential of 
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exosomes [21, 22]. It was also confirmed in a previous study that the label is stable when 
incubated in PBS containing 20% fetal bovine serum [22]. 
 
Evaluation of exosome recovery rate after filtration sterilization 
gLuc-LA-labeled exosomes in 200 μL of PBS or PBS containing 2% bovine serum albumin 
(BSA) (2 × 108 RLU/s/mL) were filtered through a 0.2-μm Minisart RC4 (Sartorius Stedim 
Biotech GmbH, Goettingen, Germany). Filtered samples were mixed with a sea pansy 
luciferase assay system (Picagene Dual), and the emitted chemiluminescence was measured 
with a luminometer (Lumat LB 9507; EG&G Berthhold, Bad Wildbad, Germany). Recovery 
rate of exosomes was calculated from gLuc activity. For estimation by Western blotting, 
exosomes in 200 μL of PBS or PBS containing 2% BSA (1 μg protein/mL) were filtered 
through a 0.2-μm Minisart RC4. Then, 16 μL of each sample before and after filtration was 
used for the analysis.  
 
Animals 
Five-week-old male C57BL6/J mice were purchased from Japan SLC, Inc. (Shizuoka, Japan). 
All protocols for the animal experiments were approved by the Animal Experimentation 
Committee of the Graduate School of Pharmaceutical Science of Kyoto University. The 
animal experiments were carried out in accordance with EC Directive 86/609/EEC. 
 
Analysis of clearance from blood circulation 
gLuc-LA-labeled and unlabeled exosomes were mixed to adjust the gLuc activity and protein 
amount of the exosome samples (5 × 108 RLU/s and 1 μg protein/200 μL; corresponding to 
the injection of 2.0 × 109, 2.9 × 109, and 3.1 × 109 particles of the sample collected by the 
pelleting, cushion, and gradient methods, respectively). We confirmed that the clearance of 
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labeled exosomes was not affected by mixing unlabeled exosomes. In our previous study, the 
pharmacokinetics of unlabeled exosomes was comparable to that of gLuc-LA-labeled 
exosomes [21]. Then the exosomes were intravenously injected to C57BL6/J mice via tail 
vein. Approximately 30 μL of blood was collected at 5, 10, 30, 60, 120, and 240 min after 
administration. Serum was obtained by centrifuging clotted whole blood at 8,000×g for 20 
min at 4°C. The gLuc activity in serum was measured as described above. The amount of 
exosomes in samples was normalized to the injected dose based on the gLuc activity and 
expressed as a percent of the injected dose/mL (% ID/mL). The half-life in the early stage 
(T1/2α), area under the curve (AUC), mean residence time (MRT), and clearance (CL) were 
calculated as described previously [14]. 
 
Statistical analysis 
Data were analyzed by one-way analysis of variance (ANOVA). Differences were evaluated 




B16-BL6-derived exosomes were isolated by three different ultracentrifugation-based 
methods 
Samples collected by ultracentrifugation methods or solvent precipitation were observed 
under TEM to check the morphology of exosomes (Fig. 1A). Many large aggregates and 
nonspherical lumps with diameter >1 μm were observed in the exosome sample collected by 
solvent precipitation. Figure 1B shows that these large lumps occupied a large volume, 
although their number was relatively small. As it was expected that the pharmacokinetics of 
aggregated exosomes of diameter over 1 μm would be different from that of dispersed 
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exosomes, the solvent precipitation method was excluded from further experiments. In 
contrast, vesicles of diameter approximately 100 nm were observed in the samples collected 
by all the ultracentrifugation methods. Some aggregated vesicles were observed in the 
samples collected by the pelleting and the cushion methods, although the degree of 
aggregation was much smaller in these samples than in the solvent precipitation samples. 
Figure 1C shows the particle size distribution of exosomes evaluated by the TRPS method. 
The mean diameters of Exo-pellet, Exo-cushion and Exo-gradient were 111, 109, and 85.3 
nm, respectively. Exo-pellet and Exo-cushion contained more particles over 100 nm in 
diameter than Exo-gradient. The zeta potentials of Exo-pellet, Exo-cushion, and Exo-gradient 
were −35.8, −37.5, and −36.2 mV, respectively. 
Figure 2 shows the immunoblotting of Alix, HSP70, CD63, and calnexin. Alix, 
HSP70, and CD63 are exosome marker proteins. Calnexin is a negative marker. Positive 
markers were detected in the exosomes collected by the pelleting (Exo-pellet) and the 
cushion method (Exo-cushion). Fraction 9 collected by the gradient method (Exo-gradient) 
also contained positive markers. Calnexin was not detected in the three exosome samples.  
The numbers of exosomes collected by each method were estimated by measurement 
of protein amount and particle number (Fig. 3). The protein amount of Exo-cushion and 
Exo-gradient was lower than that of Exo-pellet, whereas particle numbers were almost 
identical between the three groups.  
 
Exosomes disappeared rapidly from the blood circulation after intravenous injection 
Figure 4A shows the image of gLuc zymography of labeled exosomes. All samples displayed 
a band at the expected molecular mass of gLuc-LA (55 kDa). This result suggests that 
exosomes in all samples were labeled with gLuc-LA irrespective of the collection method. 
gLuc activity of labeled exosome was linearly related to the protein amount of exosomes 
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(Figure 4B). Figure 4C shows the time course of serum concentrations of gLuc-LA labeled 
exosomes after intravenous injection. gLuc activity disappeared from the blood circulation 
immediately, irrespective of the exosome collection method. Table I shows the 
pharmacokinetic parameters of injected exosomes. These parameters were not markedly 
different among the three methods.  
 
Recovery rate of Exo-gradient after filtration was higher than those of the other 
methods 
In practical use of exosomes, they may require sterilization before use. We accordingly 
investigated recovery rates of exosomes after sterile filtration, using gLuc-LA labeled 
exosomes suspended in PBS. After sterile filtration, approximately 9%, 7%, and 25% of gLuc 
activity were recovered for Exo-pellet, Exo-cushion, and Exo-gradient, respectively (Fig. 5A). 
When exosomes suspended in PBS containing 2% BSA were filtered, approximately 48%, 
41%, and 82% of gLuc activity were recovered for Exo-pellet, Exo-cushion, and 
Exo-gradient, respectively (Fig. 5B). The recovery rate estimated from Western blotting was 




Although several isolation methods for exosomes have been developed, the effects of 
isolation method on exosome characteristics as drug formulations have not been investigated. 
In this study, we demonstrated that the exosome isolation method affects the dispersibility of 
exosomes and their recovery rate after sterile filtration, but that the aggregation caused by the 
pelleting and cushion methods has little effect on the clearance of exosomes from the blood 
circulation after intravenous injection in mice. 
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Solvent precipitation offers the advantages of simplicity and no requirement of 
ultracentrifugation. However, we found that the sample collected by solvent precipitation 
using the ExoQuick reagent contained many large aggregates, a result in agreement with 
previous reports [19, 23]. These aggregates greater than 1 μm were much larger than those in 
exosomes collected by the centrifugation methods. In addition, as shown in figure 1B, the 
volume of nonaggregated exosomes was much lower than that collected by the other methods. 
As such large and frequent aggregations are not desirable in use of exosomes as a delivery 
carrier, the solvent precipitation method seems unsuitable for isolation of exosomes as a 
delivery carrier. 
Protein amount of the sample collected by the cushion method and gradient method 
was lower than that of the sample collected by the pelleting method. However, there was little 
difference in particle number between the pelleting and cushion methods. This disparity 
between protein amount and particle number may result from contamination with free 
proteins in the Exo-pellet samples. As shown by Lamparski et al., aggregated protein may be 
co-collected by the pelleting method, as the method cannot separate exosomes and 
high-density protein aggregates [24]. Although protein quantification is the method most 
frequently used to estimate the number of exosomes, it may overestimate this number by 
detecting contaminating proteins that are not associated with exosomes [25]. Our analyses of 
Western blotting showed that amounts of exosome marker proteins for a given amount of 
protein were different between the isolation methods. Although this difference may result 
from a difference in protein composition of exosomes, this result also suggests different 
degrees of contamination of aggregated protein for exosome samples collected by different 
methods. Thus, particle number seems to be appropriate for the evaluation of exosome yield. 
Size distribution as evaluated by tunable resistive pulse sensing and TEM images 
suggested that the pelleting and cushion methods cause aggregation of exosomes. Tauro et al. 
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and Jeppesen et al. showed that the pelleting method causes aggregation of exosomes [15, 18]. 
Our finding is in good agreement with these previous studies. These results, including ours, 
suggest that exosomes aggregate by pelleting because of the pressure against the 
ultracentrifuge tube and localized high concentration of exosomes. Exo-gradient resulted in 
more dispersibility than the other methods as the pressure and localized high concentration of 
exosomes may not occur with this method. The results of this study suggest that the high 
dispersibility of Exo-gradient results in high recovery after sterile filtration. Thus, the 
gradient method seems to be suitable for applications of exosomes to drug delivery. 
To evaluate clearance from blood circulation and recovery rate after sterile filtration, 
we used gLuc-LA labeled exosomes. The results shown in Figure 4A and 4B suggest that 
gLuc-LA can be used to label exosomes irrespective of the isolation method. Calculated gLuc 
signal per particle was 0.98, 0.73, and 0.72 RLU/s gLuc activity per particle in the samples 
collected by the pelleting, cushion, and gradient methods, respectively. Our previous study 
using a radioactive probe [20] showed that a single exosome was labeled with approximately 
43 molecules of streptavidin–lactadherin fusion protein when the plasmid encoding 
streptavidin–lactadherin was introduced to exosome-producing cells. As both gLuc-LA and 
streptavidin–lactadherin bind to exosome by the interaction of lactadherin with exosomes, it 
is expected that the labeling efficiency of gLuc-LA is similar to that of 
streptavidin–lactadheirn. This assumption strongly suggests that almost all of the exosomes 
were labeled with gLuc-LA, although detailed investigation is needed in future. 
The clearance rates of the exosomes from the blood circulation were comparable with 
those observed in our previous study [21]. We previously showed that intravenously injected 
exosomes accumulate in the liver, spleen, and lung [20]. We also reported that uptake of 
exosomes by macrophages is an important factor in rapid disappearance from the blood 
circulation [22]. Given that exosomes have phosphatidylserine and many membrane proteins 
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that could be recognized by the reticuloendothelial system [26, 27], clearance of exosomes 
from the blood circulation may be dependent on these molecules rather than the dispersibility 
of exosomes relative to that of exosomes collected by ultracentrifugation methods. 
The aggregation of exosomes may be the reason for the low recovery rate of 
exosomes after sterile filtration. gLuc activity measurement and Western blotting for Alix 
similarly indicated that the recovery rate of Exo-gradient was higher than that of the other 
samples. This finding is reasonable, based on the consideration that more large than small 
particles are trapped by filters. The recovery rates were lower than 30% when exosomes were 
suspended in PBS. The recovery rate may be influenced by factors such as the pore size and 
materials of the filter, similar to the case for the filtration of BSA and polysaccharides [28, 
29]. This low recovery rate after sterile filtration is in accord with a previous study [24], in 
which at least 80% exosomes collected by differential centrifugation were trapped by 
filtration. Given that the recovery rate was improved by addition of 2% BSA, BSA may 
inhibit nonspecific adsorption of exosomes to the cellulose filter. Given that cellulose is an 
uncharged material that hardly adsorbs electronegative viruses [30], most of the adsorption 
was probably caused by hydrophobic and not electrostatic interaction. However, BSA did not 
change the tendency of Exo-gradient to pass through the filter more efficiently than the other 
exosomes. This result supports the speculation that trapping of aggregated exosomes by the 
filter decreased the recovery rate after sterile filtration. Approximately, 50% of Exo-pellet 
and Exo-cushion and 20% of Exo-gradient were trapped on the filter even in the presence of 
BSA, although these samples contained few aggregates over 200 nm and thus larger than the 
pore size of the filter. The difference in particle counting between size measurement and 
sterile filtration experiments may account for this discrepancy. In the size distribution 
measurement, an exosome and an aggregate of exosomes were counted as one particle. In 
contrast, gLuc activity of an aggregate is much higher than that of dispersed exosomes. This 
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result also implies that exosomes whose diameter was under 200 nm were also trapped by the 
filter. Liposomes smaller than the pore size of the ultrafiltration membrane caused pore 
constriction or blockage and decreased flux [31]. A similar event may occur during sterile 
filtration of exosomes. In particular, aggregated exosomes are more likely to cause blockage, 
given that most aggregates are not sphere shaped, and the greatest diameter of the aggregates 
may exceed the measured value. 
 
Conclusion 
In the present study, we showed that isolation methods of exosomes affect the dispersibility 
of exosomes and the recovery rate of exosomes after sterile filtration, whereas they cause 
little difference in the clearance from the blood circulation. These results provide useful 
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Figure 1. (A) Transmission electron microscopy (TEM) images of collected exosomes. TEM 
images of samples collected by pelleting, cushion, and gradient methods and by solvent 
precipitation. Scale bar in the image of the sample from the precipitation method represents 
500 nm, and scale bars in the other images represent 100 nm. (B) Histograms of particle size 
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distribution obtained by analyzing the TEM images. Vertical axis of larger histograms 
shows % population by number (by count) and that of the smaller one shows % population by 
occupied area (by area). (C) Histograms of particle size distribution determined by TRPS. 
Figure 2. Confirmation of marker proteins in exosome preparations. Western blotting of 
samples by anti-Alix, anti-HSP70, anti-CD63, and anti-calnexin antibody. 
Figure 3. Yield of exosomes by each method. Yield of exosomes was estimated by (A) 
protein amount quantification and (B) particle number determined by tunable resistive pulse 
sensing. These results are expressed as means ± standard deviations (SDs) (n = 4). *, p < 0.05 
Figure 4. (A, B) Confirmation of gLuc-LA labeling of each sample. (A) gLuc zymography 
and (B) dilution curve of gLuc-LA labeled exosomes collected by the three 
ultracentrifugation-based methods. (C) Time course of serum concentrations in each sample 
in mice after intravenous injection of Exo-pellet (circles), Exo-cushion (squares), and 
Exo-gradient (triangles). These results are expressed as means ± standard deviations (SDs) (n 
= 3). 
Figure 5. Recovery rate after sterile filtration. Recovery rate of Exo-pellet (closed column), 
Exo-cushion (gray column), and Exo-gradient (white column) suspended in (A) 
phosphate-buffered saline (PBS) or (B) PBS containing 2% BSA after sterile filtration by 
0.2-μm syringe filter estimated by measuring gLuc activity. These results are expressed as 
means ± standard deviations (SDs) (n = 3). *, p < 0.05. (C) and (D) Western blotting of 
samples diluted in (C) PBS or (D) PBS containing 2% BSA before and after filtration.  
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